STOCK TITAN

Coherus BioSciences Management to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Coherus BioSciences, Inc. (Nasdaq: CHRS) to Present at 42nd Annual J.P. Morgan Healthcare Conference
Positive
  • None.
Negative
  • None.

REDWOOD CITY, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” Nasdaq: CHRS), today announced that senior management will present at the upcoming 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 9:45 a.m. Pacific Time. The presentation and Q&A session will be accessible via Webcast through a link posted on the Investor Events Calendar section of the Coherus website: https://investors.coherus.com/upcoming-events. This webcast will be available for replay until February 9, 2024.

Coherus Contact Information:
Jami Taylor, Head of Investor Relations
Coherus Biosciences, Inc.
IR@coherus.com

 


FAQ

When will Coherus BioSciences, Inc. present at the 42nd Annual J.P. Morgan Healthcare Conference?

Coherus BioSciences, Inc. will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 9:45 a.m. Pacific Time.

How can I access the presentation and Q&A session?

The presentation and Q&A session will be accessible via Webcast through a link posted on the Investor Events Calendar section of the Coherus website.

Until when will the webcast be available for replay?

The webcast will be available for replay until February 9, 2024.

What is the contact information for Coherus BioSciences, Inc.?

The contact person is Jami Taylor, Head of Investor Relations, and the email is IR@coherus.com.

Coherus BioSciences, Inc.

NASDAQ:CHRS

CHRS Rankings

CHRS Latest News

CHRS Stock Data

124.43M
110.58M
1.39%
70.1%
27.35%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
REDWOOD CITY